Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 315

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 315
---
(k) contribution of $19,326 and $0, respectively, for the fiscal
                                            year ended December 31, 2024.

(3)During
                                            2023, Mr. Rosén agreed to defer all salary compensation and to reduce his salary to
                                            $84,000 beginning on October 1, 2023. The deferred compensation is recorded in accrued compensation
                                            as of December 31, 2023. No interest was accrued or due on the deferred compensation for
                                            2023.

On
September 29, 2023, Mr. Rosén agreed to forgive $1,433,938 of earned compensation in exchange for 710,344 options to purchase
common stock, 430,181 restricted stock units, and $179,242 to be paid out as a bonus upon an IPO. The options to purchase common stock
have a strike price of $1.33. On December 18, 2023, the restricted stock units issued on September 29, 2023 were cancelled and reissued
as part of an additional forgiveness, whereby Mr. Rosén agreed to forgive the $179,242 of accrued bonus in exchange for 88,909
options to purchase common stock and an additional 67,215 restricted stock units (total of 497,392 restricted stock units). The options
to purchase common stock have a strike price of $1.33.

103

(4)Includes
                                            healthcare benefits and 401(k) contribution of $4,286 and $0, respectively, for
                                            the fiscal year ended December 31, 2023.

(5)Includes
                                            healthcare benefits and 401(k) contribution of $0 and $0, respectively, for
                                            the fiscal year ended December 31, 2024.

(6)During
                                            2023, Mr. Elmasri, through his consulting company, Titan Advisory Services, LLC (“Titan”) agreed to defer all salary compensation and to reduce his salary to $250,000
                                            beginning on February 1, 2023, and further reduced to $60,000 beginning on October 1, 2023.
                                            The deferred compensation is recorded in accrued compensation as of December 31, 2023. No
                                            interest was accrued or due on the deferred compensation for 2023. Mr. Elmasri and his wife are the only shareholders of Titan.

On
September 29, 2023, Mr. Elmasri